5Lars C P, Kazunori T, Hiroshi K, et al. Heparan/chondroitin sulfate biosynthesis structure and mechanism of human glucuronyl transfer- ase[ J]. J Biol Chem,2000,275 (44) :34580-34585.
6Volpi N. Analytical aspects of pharmaceutical grade chondroitin sul- fates[J]. J Pharma Sci,2007,96(12) :3168-3180.
7中国药典[S].二部,2005:170,335.
8Nicola V. Disaccharide mapping of chondroitin sulfate of different origins by high-performance capillary electrophoresis and hlgh-per- formance liquid chromatography [ J ]. Carbohydr Polym, 2004,55 : 273-281.
9Sim J S ,Jun G J ,Toida T, et al. Quantitative analysis of chondroitin sulfate in raw materials,ophthalmic olutions, soft capsules and liq- uid preparations [ J ]. J Chromatogr B, 2005,818 : 133-139.
10Sakai S, Otake E, Toida T, et al. Identification of the origin of chondroitin sulfate in " health foods" [ J~. Chem Pharm Bull ( To-kyo ), 2007,55 ( 2 ) : 299 -303.
8Cho S Y, Sim J S, Jeong C S, et al. Effects of low molecular weight chondroitin sulfate on type II collagen-induced arthritis in DBA/1J mice[J]. Biol Pharm Bull, 2004, 27 (1): 47-51.
9Lamari F N. The potential of chondroitin sulfate as a therapeutic agent[J]. Connect Tissue Res, 2008, 49 (3): 289-292.
10Hochberg M C, Clegg D O. Potential effects of chondroitin sulfate on joint swelling: a GAIT report[J]. Osteoarthritis Cartilage, 2008, 16 Suppl 3: S22-24.
